Composto, composição farmacêutica e uso de um composto
a presente invenção refere-se a derivados da imidazolona que apresentam propriedades inibitórias da elastase neutrofílica humana, e seu uso na terapia. Compounds of formula (I) defined herein exhibit human neutrophil elastase inhibitory properties and are useful for the treatment of disease or condi...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | por |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ANDREW STEPHEN ROBERT JENNINGS CAPALDI CARMELIDA ARMANI ELISABETTA ROBERT ANDREW HEALD JONATHAN MARK SUTTON |
| description | a presente invenção refere-se a derivados da imidazolona que apresentam propriedades inibitórias da elastase neutrofílica humana, e seu uso na terapia.
Compounds of formula (I) defined herein exhibit human neutrophil elastase inhibitory properties and are useful for the treatment of disease or conditions in which HNE is implicated. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BR112018074608B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BR112018074608B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BR112018074608B13</originalsourceid><addsrcrecordid>eNrjZLB0zs8tyC8uyddRSAazMg8vP7w4XyEtsSg3MfnwqtKSzOREhVSF0uJ8hRQglQtVVpLPw8CalphTnMoLpbkZVN1cQ5w9dFML8uNTiwsSk1PzUkvinYIMDY0MDC0MzE3MDCycDI2JVQcApxkyHw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Composto, composição farmacêutica e uso de um composto</title><source>esp@cenet</source><creator>ANDREW STEPHEN ROBERT JENNINGS ; CAPALDI CARMELIDA ; ARMANI ELISABETTA ; ROBERT ANDREW HEALD ; JONATHAN MARK SUTTON</creator><creatorcontrib>ANDREW STEPHEN ROBERT JENNINGS ; CAPALDI CARMELIDA ; ARMANI ELISABETTA ; ROBERT ANDREW HEALD ; JONATHAN MARK SUTTON</creatorcontrib><description>a presente invenção refere-se a derivados da imidazolona que apresentam propriedades inibitórias da elastase neutrofílica humana, e seu uso na terapia.
Compounds of formula (I) defined herein exhibit human neutrophil elastase inhibitory properties and are useful for the treatment of disease or conditions in which HNE is implicated.</description><language>por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240123&DB=EPODOC&CC=BR&NR=112018074608B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240123&DB=EPODOC&CC=BR&NR=112018074608B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ANDREW STEPHEN ROBERT JENNINGS</creatorcontrib><creatorcontrib>CAPALDI CARMELIDA</creatorcontrib><creatorcontrib>ARMANI ELISABETTA</creatorcontrib><creatorcontrib>ROBERT ANDREW HEALD</creatorcontrib><creatorcontrib>JONATHAN MARK SUTTON</creatorcontrib><title>Composto, composição farmacêutica e uso de um composto</title><description>a presente invenção refere-se a derivados da imidazolona que apresentam propriedades inibitórias da elastase neutrofílica humana, e seu uso na terapia.
Compounds of formula (I) defined herein exhibit human neutrophil elastase inhibitory properties and are useful for the treatment of disease or conditions in which HNE is implicated.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB0zs8tyC8uyddRSAazMg8vP7w4XyEtsSg3MfnwqtKSzOREhVSF0uJ8hRQglQtVVpLPw8CalphTnMoLpbkZVN1cQ5w9dFML8uNTiwsSk1PzUkvinYIMDY0MDC0MzE3MDCycDI2JVQcApxkyHw</recordid><startdate>20240123</startdate><enddate>20240123</enddate><creator>ANDREW STEPHEN ROBERT JENNINGS</creator><creator>CAPALDI CARMELIDA</creator><creator>ARMANI ELISABETTA</creator><creator>ROBERT ANDREW HEALD</creator><creator>JONATHAN MARK SUTTON</creator><scope>EVB</scope></search><sort><creationdate>20240123</creationdate><title>Composto, composição farmacêutica e uso de um composto</title><author>ANDREW STEPHEN ROBERT JENNINGS ; CAPALDI CARMELIDA ; ARMANI ELISABETTA ; ROBERT ANDREW HEALD ; JONATHAN MARK SUTTON</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BR112018074608B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ANDREW STEPHEN ROBERT JENNINGS</creatorcontrib><creatorcontrib>CAPALDI CARMELIDA</creatorcontrib><creatorcontrib>ARMANI ELISABETTA</creatorcontrib><creatorcontrib>ROBERT ANDREW HEALD</creatorcontrib><creatorcontrib>JONATHAN MARK SUTTON</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ANDREW STEPHEN ROBERT JENNINGS</au><au>CAPALDI CARMELIDA</au><au>ARMANI ELISABETTA</au><au>ROBERT ANDREW HEALD</au><au>JONATHAN MARK SUTTON</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Composto, composição farmacêutica e uso de um composto</title><date>2024-01-23</date><risdate>2024</risdate><abstract>a presente invenção refere-se a derivados da imidazolona que apresentam propriedades inibitórias da elastase neutrofílica humana, e seu uso na terapia.
Compounds of formula (I) defined herein exhibit human neutrophil elastase inhibitory properties and are useful for the treatment of disease or conditions in which HNE is implicated.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | por |
| recordid | cdi_epo_espacenet_BR112018074608B1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Composto, composição farmacêutica e uso de um composto |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T06%3A52%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ANDREW%20STEPHEN%20ROBERT%20JENNINGS&rft.date=2024-01-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBR112018074608B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |